The Regulation (EU) 2021/2282 on health technology assessment (HTAR) entered into force on 11 January 2022 and will apply from 12 January 2025.
In the preparatory phase for the implementation of the HTAR (January 2022 – January 2025), this webpage aims at informing national authorities, health technology developers and stakeholders about the development of implementing legislation in accordance with the powers conferred to the Commission by the co-legislators. It will also inform about other activities related to the future application of the new legal provisions. This information will be part of the implementing rolling plan published on this page. After their setting up, this page will also include information about the Coordination Group and, at a later stage, about the Stakeholder Network.
In the implementation phase of the HTAR (beyond January 2025, when joint HTA work will start), this webpage will include all the information required by Article 30.3 of the HTAR.
Implementation rolling plan
The rolling plan below contains a list of key activities that the European Commission has carried out or intends to carry out in preparation for the implementation of Regulation (EU) 2021/2282. The plan is subject to regular review in order to provide national authorities, health technology developers and stakeholders with the most updated information.
Member State Coordination Group on HTA (HTACG)
The HTAR established the Coordination Group on Health Technology Assessment (the ‘HTACG’) composed of Member States’ representatives, mainly from HTA authorities and bodies.